Eric Laub | VP, IR |
Richard Murray | President, CEO & Director |
Elizabeth Trehu | Chief Medical Officer |
Kimberlee Drapkin | Chief Financial Officer & Treasurer |
Dmitri Wiederschain | Chief Scientific Officer |
Boris Peaker | Cowen and Company |
Steven Seedhouse | Raymond James & Associates |
Edward Tenthoff | Piper Sandler & Co. |
Cory Kasimov | JPMorgan Chase & Co. |
David Dai | SMBC |
Arthur He | H.C. Wainwright & Co. |
Nicholas Abbott | Wells Fargo Securities |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics First Quarter 2022 Earnings Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Eric Laub with Jounce Therapeutics. Please go ahead.